Exit
Register
Login
2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors: Clinical Implications & Challenges of Antibody Drug Conjugates
Tarlatamab in Neuroendocrine Tumors: Clinical Implications & Challenges of Antibody Drug Conjugates
Finish Course
You need to enroll in this course to view this chapter
This chapter is locked
Tarlatamab in Neuroendocrine Tumors: Clinical Implications & Challenges of Antibody Drug Conjugates
Enroll
0% Course Complete